Peptide supply chain (revision 1)
Old revision·17:50, 4 Oct 2024·TrialsTabitha
This is an old revision of this page, as it stood at 17:50, 4 Oct 2024, saved by TrialsTabitha with the summary start article on the process step. It may differ substantially from the current revision, and any error it contains may since have been corrected.
| Peptide supply chain | |
|---|---|
| Topic infobox · conventions |
A research peptide passes through at least six operations between a resin bead and a purchaser's hand: solid-phase synthesis, cleavage from the resin, preparative purification, lyophilisation, filling and closure, and freight — frequently followed by a period in a regional warehouse and, in some arrangements, by repackaging.[1]
Each operation has a characteristic failure mode, and the great majority of quality observations made downstream are attributable to one of them rather than to a general property of the material or the seller.[2] Knowing which stage produces which observation is what allows a purchaser to read a certificate as evidence about something rather than as a number.
References
- ^ United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.
- ^ World Health Organization, Good Manufacturing Practices for Pharmaceutical Products: Main Principles, WHO Technical Report Series. Sets out the stage-by-stage controls that unregulated supply is not obliged to operate.
Categories: